# A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma

> **NCT01553981** · PHASE3 · COMPLETED · sponsor: **Sanjay Gandhi Postgraduate Institute of Medical Sciences** · enrollment: 40 (actual)

## Conditions studied

- Lung Diseases, Interstitial

## Interventions

- **DRUG:** Tadalafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01553981
- **Lead sponsor:** Sanjay Gandhi Postgraduate Institute of Medical Sciences
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-04
- **Final completion:** 2014-05
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2015-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01553981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01553981, "A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01553981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*